Viewing Study NCT02963168


Ignite Creation Date: 2025-12-24 @ 5:55 PM
Ignite Modification Date: 2026-02-04 @ 3:48 PM
Study NCT ID: NCT02963168
Status: UNKNOWN
Last Update Posted: 2019-10-17
First Post: 2016-10-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A DRF Study to Evaluate Safety, Tolerability, PK, and Activity of Oradoxel Monotherapy in Subjects w Adv. Malignancies
Sponsor: Athenex, Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2017-04-20
Start Date Type: ACTUAL
Primary Completion Date: 2020-03-30
Primary Completion Date Type: ESTIMATED
Completion Date: 2020-04-30
Completion Date Type: ESTIMATED
First Submit Date: 2016-10-07
First Submit QC Date: None
Study First Post Date: 2016-11-15
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2019-10-15
Last Update Post Date: 2019-10-17
Last Update Post Date Type: ACTUAL